Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03897036
Title Treatment Duration Increment and Pharmacodynamic Study of CX-4945 in Patients With Basal Cell Carcinoma (BCC)
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Senhwa Biosciences, Inc.
Indications

basal cell carcinoma

Therapies

Silmitasertib

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.